Menu

Category: News Alert

News Alert

Novo Nordisk Files Suit to Block $100,000 Arkansas Fine for 340B Contract Pharmacy Violations

October 13, 2023 William Newton Washington Correspondent Views

Novo Nordisk and the Arkansas Insurance Department are at odds over whether a federal district court should intervene in the enforcement of Arkansas' 340B contract pharmacy law.

Danish drug giant Novo Nordisk filed suit Thursday to stop a proposed $100,000 fine from Arkansas over alleged violations of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Read More »

News Alert

BMS Expands 340B Contract Pharmacy Conditions, Including for Grantees

October 6, 2023 Tom Mirga Editor at Large Views

Bristol Myers Squibb

Bristol Myers Squibb has announced updates to its conditions on pharmaceutical sales involving contract pharmacies.

Bristol Myers Squibb (BMS) announced updates to its conditions on pharmaceutical sales involving contract pharmacies, effective Nov. 1. BMS outlined [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Read More »

News Alert

Ranking GOP Senator on Key Committee Opens Investigation into 340B Hospital Revenue

September 29, 2023 William Newton Washington Correspondent Views

Sen. Bill Cassidy, ranking Republican on the Senate HELP Committee, does not appear to have the authority to compel hospitals to respond to his inquiry on 340B revenue.

The top Republican on an influential Senate committee has opened an investigation into how two major health systems use revenue [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Read More »

News Alert

House Subcommittee Clashes Over 340B Role in Drug Shortages

September 14, 2023 William Newton Washington Correspondent Views

Legislation sponsored by Rep. Cathy McMorris Rodgers (R-Wash.) was the focus of a partisan clash during a Sept. 14 hearing over changes it would implement for the 340B program.

A House subcommittee hearing today exposed partisan divisions over the 340B program’s impact on generic drug shortages. The Sep. 14 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Read More »

News Alert

UCB Tightens 340B Contract Pharmacy Restrictions for Hospitals

September 5, 2023 William Newton Washington Correspondent Views

UCB signage and building

UCB announced it will tighten its existing 340B contract restrictions on hospitals beginning Oct. 2.

Belgium drug maker UCB will add restrictions on 340B contract pharmacy use for hospitals starting Oct. 2, according to a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Read More »

News Alert

EMD Serono Extends Hospital 340B Contract Pharmacy Conditions to All Products

September 1, 2023 William Newton Washington Correspondent Views

EMD Serono announced extended 340B contract pharmacy restrictions for hospitals in a manufacturer notice on Sept. 1.

Drug manufacturer EMD Serono (EMDS) today announced 340B contract pharmacy restrictions for hospitals will expand Oct. 1 to all of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Read More »

News Alert

UPDATED: Astellas and AstraZeneca Make 340B Contract Pharmacy Moves

July 3, 2023 Rich Daly Editor in Chief Views

Astellas Pharma

Astellas is the third drugmaker to loosen or end its 340B contract pharmacy restrictions in Arkansas and Louisiana in response to state laws.

Drug manufacturers Astellas and AstraZeneca announced today separate contract pharmacy policies for 340B providers that will go into effect in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Read More »

News Alert

Boehringer Ingelheim Extends 340B Contract Pharmacy Conditions to All Covered Entities

June 23, 2023 Tom Mirga Editor at Large Views

Boehringer Ingelheim

Boehringer Ingelheim today stiffened its conditions on 340B pricing involving deliveries to contract pharmacies and extended them to all types of covered entities.

Drug manufacturer Boehringer Ingelheim announced this morning that, starting Aug. 1, all covered entity types will be subject to its conditions on 340B pricing when entities use contract pharmacies to dispense BI products. Until now, its conditions have applied to

…

Read More »

News Alert

Six Democratic and Republican U.S. Senators Ask 340B Stakeholders for “Bipartisan Policy Solutions”

June 16, 2023 Tom Mirga Editor at Large Views

Senate 340B RFI

A bipartisan group of six U.S. senators today sought 340B stakeholders' best advice on subjects including 340B contract pharmacy, duplicate discount prevention, accountability, and ensuring that program benefits accrue to covered entities and their patients.

Six Democratic and Republican U.S. senators this morning asked 340B drug pricing program stakeholders for input on “bipartisan policy solutions that would ensure the program has stability and oversight to continue to achieve its original intention of serving eligible patients.”

…

Read More »

News Alert

Bausch Health Tightens its Conditions on 340B Pricing to All Covered Entities

June 12, 2023 Tom Mirga Editor at Large Views

Bausch Health

Bausch Health today tightened its conditions on 340B pricing involving deliveries to contract pharmacies.

Bausch Health this morning updated its conditions on 340B pricing involving deliveries to contract pharmacies to all covered entities. It is the fifth drug maker this month to either impose such conditions for the first time (Organon and …

Read More »